Autosomal dominant retinitis pigmentosa in Norway: a 20-year clinical follow-up study with molecular genetic analysis. Two novel rhodopsin mutations: 1003delG and I179F-Reference-Cited by-同舟云学术

Autosomal dominant retinitis pigmentosa in Norway: a 20-year clinical follow-up study with molecular genetic analysis. Two novel rhodopsin mutations: 1003delG and I179F

Published:2006-11-27 Issue:3 Volume:85 Page:287-297
ISSN:1395-3907
Container-title:Acta Ophthalmologica Scandinavica
language:en
Short-container-title:

Author:

Grøndahl Jan,Riise Ruth,Heiberg Arvid,Leren Trond,Christoffersen Terje,Bragadottir Ragnheidur

Publisher

Wiley

Subject

Ophthalmology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0420.2006.00820.x/fullpdf

Reference13 articles.

1. Electroretinographic diagnosis in families with X-linked retinitis pigmentosa;Andréasson;Acta Ophthalmol,1990

2. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment;Berson;Arch Ophthalmol,2004a

3. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa;Berson;Arch Ophthalmol,1993

4. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment;Berson;Arch Ophthalmol,2004b

5. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations;Berson;Invest Ophthalmol Vis Sci,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview on the Genetic Etiology, Testing, and Therapeutic Options for Retinitis Pigmentosa;Genetics of Ocular Diseases;2022

2. Stationary and Progressive Phenotypes Caused by the p.G90D Mutation in Rhodopsin Gene;International Journal of Molecular Sciences;2021-02-21

3. Spectrum-frequency and genotype–phenotype analysis of rhodopsin variants;Experimental Eye Research;2021-02

4. Clinical and Genetic Analysis of a European Cohort with Pericentral Retinitis Pigmentosa;International Journal of Molecular Sciences;2019-12-20

5. Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials;International Journal of Molecular Sciences;2019-10-27